arrow
Y

Yuji Minegishi

nippon medical school
H指数:30
被引数:3,053

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy
2024-05-031
OAAI
Promotive clinical effects of pembrolizumab with necitumumab in patients having advanced non-small cell lung cancer with PD-L1 expression of 50% or higher in a phase II study (K-TAIL-202)
2024-04-050
PRE
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060

NSCLC患者脑转移瘤放疗免疫治疗: NEJ060

2024-04-013
OA
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial
2022-03-3151
PRE
A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027

一线阿法替尼治疗 ≥ 75岁EGFR突变阳性晚期非小细胞肺癌患者的II期研究: 日本东北研究组试验NEJ027

2021-03-0116
OAAI
Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis
2018-01-0143
PREAI
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutation

EGFR酪氨酸激酶和ALK抑制剂对EGFR突变共存的EML4-ALK-rearranged非小细胞肺癌的活性

2013-05-2950
OAAI